$MANH
Manhattan Associates Inc

2023 Q4 Form 10-Q Financial Statement

#000095017023055604 Filed on October 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $238.3M $238.4M
YoY Change 20.27% 20.36%
Cost Of Revenue $106.7M $111.4M
YoY Change 18.58% 15.89%
Gross Profit $131.5M $127.0M
YoY Change 21.67% 24.58%
Gross Profit Margin 55.2% 53.26%
Selling, General & Admin $39.83M $39.02M
YoY Change 14.56% 14.32%
% of Gross Profit 30.28% 30.72%
Research & Development $31.33M $33.09M
YoY Change 15.5% 12.66%
% of Gross Profit 23.82% 26.06%
Depreciation & Amortization $1.552M $1.400M
YoY Change 3.05% -15.87%
% of Gross Profit 1.18% 1.1%
Operating Expenses $72.66M $72.11M
YoY Change 14.62% 10.65%
Operating Profit $58.86M $53.45M
YoY Change 31.67% 45.36%
Interest Expense $5.904M -$400.0K
YoY Change 492.77% -125.0%
% of Operating Profit 10.03% -0.75%
Other Income/Expense, Net $867.0K $1.739M
YoY Change 4.71% 7.88%
Pretax Income $59.73M $55.19M
YoY Change 31.18% 43.78%
Income Tax $11.00M $5.766M
% Of Pretax Income 18.41% 10.45%
Net Earnings $48.74M $49.42M
YoY Change 28.7% 66.55%
Net Earnings / Revenue 20.46% 20.73%
Basic Earnings Per Share $0.80
Diluted Earnings Per Share $0.78 $0.79
COMMON SHARES
Basic Shares Outstanding 61.57M 61.67M
Diluted Shares Outstanding 62.31M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $270.7M $182.3M
YoY Change 20.08% -7.49%
Cash & Equivalents $270.7M $182.3M
Short-Term Investments
Other Short-Term Assets $5.195M $27.20M
YoY Change -77.55% 4.07%
Inventory
Prepaid Expenses $20.71M
Receivables $181.2M $183.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $479.2M $392.9M
YoY Change 15.36% 7.14%
LONG-TERM ASSETS
Property, Plant & Equipment $11.80M $11.27M
YoY Change -61.45% -66.3%
Goodwill $62.24M $62.23M
YoY Change 0.01% 0.02%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $32.45M $31.14M
YoY Change -47.65% -40.54%
Total Long-Term Assets $194.2M $180.1M
YoY Change 25.43% 21.69%
TOTAL ASSETS
Total Short-Term Assets $479.2M $392.9M
Total Long-Term Assets $194.2M $180.1M
Total Assets $673.4M $573.0M
YoY Change 18.1% 11.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.51M $25.25M
YoY Change -4.64% -7.7%
Accrued Expenses $100.6M $93.60M
YoY Change 27.26% 10.03%
Deferred Revenue $237.8M $213.4M
YoY Change 13.88% 26.01%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $365.9M $332.8M
YoY Change 15.94% 17.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.47M $13.83M
YoY Change -58.73% -57.61%
Total Long-Term Liabilities $11.47M $13.83M
YoY Change -58.73% -57.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $365.9M $332.8M
Total Long-Term Liabilities $11.47M $13.83M
Total Liabilities $377.4M $346.7M
YoY Change 9.9% 9.5%
SHAREHOLDERS EQUITY
Retained Earnings $304.7M $238.3M
YoY Change 20.1% 5.39%
Common Stock $615.0K $616.0K
YoY Change -0.97% -1.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $278.3M $210.1M
YoY Change
Total Liabilities & Shareholders Equity $673.4M $573.0M
YoY Change 18.1% 11.32%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $48.74M $49.42M
YoY Change 28.7% 66.55%
Depreciation, Depletion And Amortization $1.552M $1.400M
YoY Change 3.05% -15.87%
Cash From Operating Activities $88.32M $58.60M
YoY Change 59.92% 46.79%
INVESTING ACTIVITIES
Capital Expenditures $1.930M $1.100M
YoY Change -179.26% -157.62%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.930M -$1.100M
YoY Change -20.74% -42.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -347.0K -26.60M
YoY Change -98.64% -48.09%
NET CHANGE
Cash From Operating Activities 88.32M 58.60M
Cash From Investing Activities -1.930M -1.100M
Cash From Financing Activities -347.0K -26.60M
Net Change In Cash 86.04M 30.90M
YoY Change 214.45% -333.54%
FREE CASH FLOW
Cash From Operating Activities $88.32M $58.60M
Capital Expenditures $1.930M $1.100M
Free Cash Flow $86.39M $57.50M
YoY Change 49.82% 37.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001056696
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-23999
dei Entity Registrant Name
EntityRegistrantName
MANHATTAN ASSOCIATES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-2373424
dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Windy Ridge Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Tenth Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
955-7070
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
MANH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61565157
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
182312000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225463000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5367000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6009000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
183377000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
166767000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27170000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23145000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
392859000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
415375000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11266000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12803000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19976000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17794000
CY2023Q3 us-gaap Goodwill
Goodwill
62228000
CY2022Q4 us-gaap Goodwill
Goodwill
62230000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
55523000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37206000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31143000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24770000
CY2023Q3 us-gaap Assets
Assets
572995000
CY2022Q4 us-gaap Assets
Assets
570178000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
25253000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25701000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67187000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54469000
CY2023Q3 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
26429000
CY2022Q4 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
24569000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
213440000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
208807000
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
517000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2049000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
332826000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
315595000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16237000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14065000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13827000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13718000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
manh Expected Percentage Of Revenue Recognized From Remaining Performance Obligation Over Twenty Four Months
ExpectedPercentageOfRevenueRecognizedFromRemainingPerformanceObligationOverTwentyFourMonths
0.40
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61562480
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61562480
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62191570
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62191570
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
616000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
621000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
238315000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
253711000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28826000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27532000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
210105000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
226800000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
572995000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
570178000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238441000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
198101000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
690470000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
568981000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33093000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29375000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
95487000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84754000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17650000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15742000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
54278000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
47881000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21371000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18392000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61561000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54963000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1440000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1664000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4247000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5157000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
184993000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
161331000
us-gaap Costs And Expenses
CostsAndExpenses
539454000
us-gaap Costs And Expenses
CostsAndExpenses
460986000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
53448000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36770000
us-gaap Operating Income Loss
OperatingIncomeLoss
151016000
us-gaap Operating Income Loss
OperatingIncomeLoss
107995000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1739000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1612000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2923000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4593000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55187000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38382000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
153939000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
112588000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5766000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8708000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26107000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21497000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29674000
us-gaap Net Income Loss
NetIncomeLoss
127832000
us-gaap Net Income Loss
NetIncomeLoss
91091000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.8
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.45
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61639000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62592000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61902000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62917000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62310000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63165000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62501000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63483000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29674000
us-gaap Net Income Loss
NetIncomeLoss
127832000
us-gaap Net Income Loss
NetIncomeLoss
91091000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2086000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3566000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1294000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8781000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47335000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26108000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
126538000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82310000
us-gaap Profit Loss
ProfitLoss
127832000
us-gaap Profit Loss
ProfitLoss
91091000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4247000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5157000
us-gaap Share Based Compensation
ShareBasedCompensation
53598000
us-gaap Share Based Compensation
ShareBasedCompensation
44209000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-42000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
20000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-18359000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-20736000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-922000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2933000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17168000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23384000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7747000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9190000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
13477000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
20743000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4347000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-730000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5362000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
20195000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
157859000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124402000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2761000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4152000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2761000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4152000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
195716000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
179029000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195716000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-179029000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2533000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-7872000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43151000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66651000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
225463000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
263706000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
182312000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
197055000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
170550000
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
26601000
CY2023Q3 manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
209000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
19030000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2086000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
210105000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
226800000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
195716000
manh Excise Tax Accrued
ExciseTaxAccrued
1115000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
53598000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1294000
us-gaap Net Income Loss
NetIncomeLoss
127832000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
210105000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
208735000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
51242000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
14533000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3566000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29674000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
198134000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
250644000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
179029000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
44209000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8781000
us-gaap Net Income Loss
NetIncomeLoss
91091000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
198134000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1300000000
us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize revenue on approximately 40% of these remaining performance obligations over the next 24 months with the balance recognized thereafter.
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2023Q3 manh Provision For Cost Of Return And Product Warranty Claims Recorded
ProvisionForCostOfReturnAndProductWarrantyClaimsRecorded
0
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2800000
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
900000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2100000
us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
We apply the practical expedient to expense sales commissions when the amortization period would have been one year or less.
CY2023Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2400000
CY2022Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1800000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
7000000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
5500000
CY2023Q3 us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2022Q3 us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2023Q3 us-gaap Cash
Cash
98400000
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
83900000
CY2023Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
19000000
CY2022Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
14500000
us-gaap Restricted Stock Expense
RestrictedStockExpense
53600000
us-gaap Restricted Stock Expense
RestrictedStockExpense
44200000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62310000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63165000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62501000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63483000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.104
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.227
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.170
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
CY2023Q3 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
300000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49421000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29674000
us-gaap Net Income Loss
NetIncomeLoss
127832000
us-gaap Net Income Loss
NetIncomeLoss
91091000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.8
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.45
CY2023Q3 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61639000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62592000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61902000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62917000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
671000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
573000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
599000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
566000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238441000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
198101000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
111439000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
96158000
CY2023Q3 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
72114000
CY2022Q3 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
63509000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1440000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1664000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
184993000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
161331000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
53448000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36770000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
690470000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
568981000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
323881000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
268231000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
211326000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
187598000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4247000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5157000
us-gaap Costs And Expenses
CostsAndExpenses
539454000
us-gaap Costs And Expenses
CostsAndExpenses
460986000
us-gaap Operating Income Loss
OperatingIncomeLoss
151016000
us-gaap Operating Income Loss
OperatingIncomeLoss
107995000
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-055604-index-headers.html Edgar Link pending
0000950170-23-055604-index.html Edgar Link pending
0000950170-23-055604.txt Edgar Link pending
0000950170-23-055604-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
manh-20230930.htm Edgar Link pending
manh-20230930.xsd Edgar Link pending
manh-ex31_1.htm Edgar Link pending
manh-ex31_2.htm Edgar Link pending
manh-ex32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
manh-20230930_def.xml Edgar Link unprocessable
manh-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
manh-20230930_lab.xml Edgar Link unprocessable
manh-20230930_pre.xml Edgar Link unprocessable
manh-20230930_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending